Junho Choe1,2,17, Shuibin Lin1,2,3,17, Wencai Zhang4, Qi Liu1,2, Longfei Wang2, Julia Ramirez-Moya1,5, Peng Du1,2, Wantae Kim6,16, Shaojun Tang7,8, Piotr Sliz2, Pilar Santisteban5, Rani E. George9,10, William G. Richards11, Kwok-Kin Wong12, Nicolas Locker13, Frank J. Slack4,14,15 & Richard I. Gregory1,2,10,14,15*
1Stem Cell Program, Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA. 2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. 3Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. 4Department of Pathology, Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA. 5Instituto de Investigaciones Biomedicas, Consejo Superior de Investigaciones Cientificas and Universidad Autonoma de Madrid (CSIC-UAM), Madrid, Spain. 6Harvard School of Dental Medicine, Boston, MA, USA. 7Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA. 8Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. 9Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. 10Department of Pediatrics, Harvard Medical School, Boston, MA, USA. 11Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA. 12Division of Hematology and Medical Oncology, NYU School of Medicine, New York, NY, USA. 13School of Biosciences and Medicine, University of Surrey, Guildford, UK. 14Harvard Initiative for RNA Medicine, Boston, MA, USA. 15Harvard Stem Cell Institute, Cambridge, MA, USA. 16Present address: Biomedical Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea. 17These authors contributed equally: Junho Choe, Shuibin Lin
*To whom correspondence may be addressed.